Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis

EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021, Vol.9 (5), p.e03971-e03971
Main Authors: Kuhlman, Justin J, Alhaj Moustafa, Muhamad, Tun, Alexander J, Menke, David M, Tun, Han W, Jiang, Liuyan
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page e03971
container_issue 5
container_start_page e03971
container_title Clinical case reports
container_volume 9
creator Kuhlman, Justin J
Alhaj Moustafa, Muhamad
Tun, Alexander J
Menke, David M
Tun, Han W
Jiang, Liuyan
description EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.
doi_str_mv 10.1002/ccr3.3971
format report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2538045942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2538045942</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_25380459423</originalsourceid><addsrcrecordid>eNqVjLFuwjAURS1UJFDLwB947GL67CSCrK2oOnaouqKHeSFGThz8bJX8PQh16NrpniMdXSGWGlYawLxYG4tVUa_1RMwNVKCghvLhD8_EgvkEABrWptIwF8NndB3GUeKRVCSPiQ5y-_qtkDlYd1dqmswu9GqPfFM_dkMbOpScrSXmJns_yhTpHv-41MroUr7cfvcS-4NMbYhoqU_Ejp_EtEHPtPjdR_H8vv16-1BDDOdMnHadY0veY08h885UxQbKqi5N8Y_0CoBxVeI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2538045942</pqid></control><display><type>report</type><title>Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis</title><source>Wiley-Blackwell Open Access Collection</source><source>PubMed Central Free</source><source>Publicly Available Content (ProQuest)</source><creator>Kuhlman, Justin J ; Alhaj Moustafa, Muhamad ; Tun, Alexander J ; Menke, David M ; Tun, Han W ; Jiang, Liuyan</creator><creatorcontrib>Kuhlman, Justin J ; Alhaj Moustafa, Muhamad ; Tun, Alexander J ; Menke, David M ; Tun, Han W ; Jiang, Liuyan</creatorcontrib><description>EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.</description><identifier>ISSN: 2050-0904</identifier><identifier>EISSN: 2050-0904</identifier><identifier>DOI: 10.1002/ccr3.3971</identifier><language>eng</language><ispartof>Clinical case reports, 2021, Vol.9 (5), p.e03971-e03971</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925,37013</link.rule.ids></links><search><creatorcontrib>Kuhlman, Justin J</creatorcontrib><creatorcontrib>Alhaj Moustafa, Muhamad</creatorcontrib><creatorcontrib>Tun, Alexander J</creatorcontrib><creatorcontrib>Menke, David M</creatorcontrib><creatorcontrib>Tun, Han W</creatorcontrib><creatorcontrib>Jiang, Liuyan</creatorcontrib><title>Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis</title><title>Clinical case reports</title><description>EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.</description><issn>2050-0904</issn><issn>2050-0904</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2021</creationdate><recordtype>report</recordtype><recordid>eNqVjLFuwjAURS1UJFDLwB947GL67CSCrK2oOnaouqKHeSFGThz8bJX8PQh16NrpniMdXSGWGlYawLxYG4tVUa_1RMwNVKCghvLhD8_EgvkEABrWptIwF8NndB3GUeKRVCSPiQ5y-_qtkDlYd1dqmswu9GqPfFM_dkMbOpScrSXmJns_yhTpHv-41MroUr7cfvcS-4NMbYhoqU_Ejp_EtEHPtPjdR_H8vv16-1BDDOdMnHadY0veY08h885UxQbKqi5N8Y_0CoBxVeI</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Kuhlman, Justin J</creator><creator>Alhaj Moustafa, Muhamad</creator><creator>Tun, Alexander J</creator><creator>Menke, David M</creator><creator>Tun, Han W</creator><creator>Jiang, Liuyan</creator><scope>7X8</scope></search><sort><creationdate>20210501</creationdate><title>Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis</title><author>Kuhlman, Justin J ; Alhaj Moustafa, Muhamad ; Tun, Alexander J ; Menke, David M ; Tun, Han W ; Jiang, Liuyan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_25380459423</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kuhlman, Justin J</creatorcontrib><creatorcontrib>Alhaj Moustafa, Muhamad</creatorcontrib><creatorcontrib>Tun, Alexander J</creatorcontrib><creatorcontrib>Menke, David M</creatorcontrib><creatorcontrib>Tun, Han W</creatorcontrib><creatorcontrib>Jiang, Liuyan</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuhlman, Justin J</au><au>Alhaj Moustafa, Muhamad</au><au>Tun, Alexander J</au><au>Menke, David M</au><au>Tun, Han W</au><au>Jiang, Liuyan</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis</atitle><jtitle>Clinical case reports</jtitle><date>2021-05-01</date><risdate>2021</risdate><volume>9</volume><issue>5</issue><spage>e03971</spage><epage>e03971</epage><pages>e03971-e03971</pages><issn>2050-0904</issn><eissn>2050-0904</eissn><abstract>EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.</abstract><doi>10.1002/ccr3.3971</doi></addata></record>
fulltext fulltext
identifier ISSN: 2050-0904
ispartof Clinical case reports, 2021, Vol.9 (5), p.e03971-e03971
issn 2050-0904
2050-0904
language eng
recordid cdi_proquest_miscellaneous_2538045942
source Wiley-Blackwell Open Access Collection; PubMed Central Free; Publicly Available Content (ProQuest)
title Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A43%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Primary%20age-related%20EBV-associated%20effusion-based%20lymphoma%20successfully%20treated%20with%20rituximab%20and%20thoracentesis&rft.jtitle=Clinical%20case%20reports&rft.au=Kuhlman,%20Justin%20J&rft.date=2021-05-01&rft.volume=9&rft.issue=5&rft.spage=e03971&rft.epage=e03971&rft.pages=e03971-e03971&rft.issn=2050-0904&rft.eissn=2050-0904&rft_id=info:doi/10.1002/ccr3.3971&rft_dat=%3Cproquest%3E2538045942%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_25380459423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2538045942&rft_id=info:pmid/&rfr_iscdi=true